Effect of salmeterol on respiratory muscle activity during exercise in poorly reversible COPD
about
Muscle function in COPD: a complex interplayImpact of bronchodilator therapy on exercise tolerance in COPD.Effect of salbutamol on lung function and chest wall volumes at rest and during exercise in COPD.Abdominal muscle and quadriceps strength in chronic obstructive pulmonary disease.Inhaled β-agonist does not modify sympathetic activity in patients with COPD.Hyperinflation and its management in COPDLong-acting beta2-agonists (LABA) in chronic obstructive pulmonary disease: efficacy and safetyBacterial lysate in the prevention of acute exacerbation of COPD and in respiratory recurrent infections.Long-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agents.No room to breathe: the importance of lung hyperinflation in COPD.Responsiveness of Various Exercise-Testing Protocols to Therapeutic Interventions in COPD.Minimal clinically important differences in pharmacological trials.Lung hyperinflation in chronic obstructive pulmonary disease: mechanisms, clinical implications and treatment.Pharmacological management of breathlessness in COPD: recent advances and hopes for the future.Aspects of skeletal muscles in chronic respiratory disease.How Do Dual Long-Acting Bronchodilators Prevent Exacerbations of Chronic Obstructive Pulmonary Disease?The preclinical toxicology of salmeterol hydroxynaphthoate.Long-acting bronchodilators improve exercise capacity in COPD patients: a systematic review and meta-analysis.Effect of bronchoscopic lung volume reduction on dynamic hyperinflation and exercise in emphysema.The Link between Reduced Inspiratory Capacity and Exercise Intolerance in Chronic Obstructive Pulmonary Disease.Effect of heliox on lung dynamic hyperinflation, dyspnea, and exercise endurance capacity in COPD patients.
P2860
Q26865732-2D52EF72-6BAC-47CD-8EDF-70EE7709C793Q33831434-F5443D2A-D97B-430D-84AC-AE25C9355B77Q35537266-7C70CF4C-F6A9-45FD-A051-CE6BF4A63B68Q35537946-F8C00602-2189-48E9-8A34-6081DB5BB927Q35618080-5D14C6EB-2369-4A29-A7FD-9883D75B9F0FQ37017336-ED57891F-7886-4C23-A48B-26E71B9DFAA2Q37115933-417268BD-BCBF-49E9-90F0-193D04AA69D2Q37224498-289A597D-D63C-4B5E-9B20-E12BAC27EB5DQ37804908-5963FC4F-FE2F-4E0E-BCA1-9E72120F723BQ38083537-5ED4E914-A68D-4A35-B379-50D7F60FF247Q38083660-5BC9C2C9-2313-4280-8A21-230731CD8854Q38175163-B82DF0B5-ED7B-4A67-9B51-B386EF913EDCQ38243468-D8DBC5C9-D984-42FD-9827-B79E232B72CEQ38817813-132987EA-4152-440D-A82A-AA74C6B7715EQ38917425-6D8A9D03-D272-4A70-81F3-C26DA65BFE70Q39030602-11189A9C-49F7-4F41-B9A8-3B01410F71E6Q43134820-F979B306-9C78-45D2-B5BF-37CEFFF9B787Q47647936-7CEBD3B5-79D5-4ADA-B21A-5D6B423E952AQ47885096-25A20E22-DDD8-4235-BEF5-958A7FB70C8AQ47923166-847519C1-F791-4668-887D-40AAAFE50052Q47960152-03B206EE-6AA1-462B-90B5-2E7DE7818F82
P2860
Effect of salmeterol on respiratory muscle activity during exercise in poorly reversible COPD
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Effect of salmeterol on respir ...... cise in poorly reversible COPD
@ast
Effect of salmeterol on respir ...... cise in poorly reversible COPD
@en
type
label
Effect of salmeterol on respir ...... cise in poorly reversible COPD
@ast
Effect of salmeterol on respir ...... cise in poorly reversible COPD
@en
prefLabel
Effect of salmeterol on respir ...... cise in poorly reversible COPD
@ast
Effect of salmeterol on respir ...... cise in poorly reversible COPD
@en
P2093
P2860
P356
P1433
P1476
Effect of salmeterol on respir ...... cise in poorly reversible COPD
@en
P2093
M I Polkey
N Donaldson
P2860
P304
P356
10.1136/THX.2003.019620
P407
P577
2004-06-01T00:00:00Z